Patent · US Active

Trimeric peptides for antisense delivery

US12168059B2 · kind B2 · utility

0Cited by
1References
23Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 29, 2019
Grant dateDec 17, 2024
Priority date
Expiry dateSep 29, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/3513
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are oligonucleotides, trimeric peptides, and peptide-oligonucleotide-conjugates. Also provided herein are methods of treating a muscle disease in a subject in need thereof, comprising administering to the subject oligonucleotides, trimeric peptides, and peptide-oligonucleotide-conjugates described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.